Published in Antimicrob Agents Chemother on May 01, 1993
External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings. Br J Clin Pharmacol (2013) 1.07
Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery. Antimicrob Agents Chemother (2006) 1.00
Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding. Antimicrob Agents Chemother (2011) 0.94
Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models. Antimicrob Agents Chemother (2004) 0.93
Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin. Antimicrob Agents Chemother (2014) 0.92
PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin. Antimicrob Agents Chemother (2011) 0.78
Factors Impacting Unbound Vancomycin Concentrations in Different Patient Populations. Antimicrob Agents Chemother (2015) 0.78
Development of a novel collagen wound model to simulate the activity and distribution of antimicrobials in soft tissue during diabetic foot infection. Antimicrob Agents Chemother (2016) 0.75
Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm (1974) 5.67
A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem (1967) 4.32
Single-dose kinetics of intravenous vancomycin. J Clin Pharmacol (1980) 2.48
Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother (1984) 2.09
Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet (1986) 2.07
Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations. Antimicrob Agents Chemother (1982) 1.97
Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrob Agents Chemother (1988) 1.72
Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis. N Engl J Med (1966) 1.51
Vancomycin disposition: the importance of age. Clin Pharmacol Ther (1984) 1.22
Ultrafiltration is theoretically equivalent to equilibrium dialysis but much simpler to carry out. Arch Biochem Biophys (1978) 1.13
A statistical method for the estimation of binding parameters in a complex system. Anal Biochem (1976) 1.03
Vancomycin serum protein binding determination by ultrafiltration. Drug Intell Clin Pharm (1988) 1.00
Vancomycin quantitation by high-performance liquid chromatography in human serum. J Chromatogr (1982) 0.99
Determination of vancomycin in human serum by high-pressure liquid chromatography. Antimicrob Agents Chemother (1985) 0.97
Protein binding of vancomycin in a patient with immunoglobulin A myeloma. Antimicrob Agents Chemother (1990) 0.89
Protein binding of glycopeptide antibiotics with diverse physical-chemical properties in mouse, rat, and human serum. J Pharmacokinet Biopharm (1987) 0.87
Activity of minocycline against Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and Serratia marcescens. Antimicrob Agents Chemother (1975) 2.92
Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis. J Periodontal Res (1979) 1.70
Leukotactic dystunction in sarcoidosis. Ann Intern Med (1976) 1.50
Interpreting tuberculosis skin tests. Lancet (1996) 1.39
Micropore filter assay of human granulocyte locomotion: problems and solutions. Clin Immunol Immunopathol (1978) 1.36
Serum-associated inhibition of leukotaxis in humans with cancer. Clin Immunol Immunopathol (1978) 1.35
Chloramphenicol: A review of its use in clinical practice. Rev Infect Dis (1981) 1.27
Flavobacterium meningosepticum meningitis in a newborn infant. Treatment with intraventricular erythromycin. J Pediatr (1974) 1.22
Aminoglycoside antibiotics moderately impair granulocyte function. Antimicrob Agents Chemother (1978) 1.20
Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun (1993) 1.11
Host defense during pregnancy: neutrophil chemotaxis and adherence. Am J Obstet Gynecol (1987) 1.07
Polymorphonuclear leukocyte adherence and chemotaxis in stressed and healthy neonates. Pediatr Res (1986) 1.07
Treatment of nocardial infection with trimethoprim and sulfamethoxazole. Am J Med (1974) 1.00
Polymorphonuclear leukocyte migration abnormalities and their significance in seriously traumatized patients. Ann Surg (1983) 1.00
Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluid. Curr Ther Res Clin Exp (1976) 0.99
Pentoxifylline enhancement of defective neutrophil function and host defense in neonatal mice. Am J Pathol (1987) 0.97
Abnormalities of neutrophil adherence in newborns. Pediatrics (1982) 0.92
Leukocytic function in malakoplakia. Arch Pathol Lab Med (1978) 0.90
Modulation of neonatal neutrophil function by pentoxifylline. Pediatr Res (1991) 0.90
Treatment of malakoplakia with trimethoprim-sulfamethoxazole. Urology (1979) 0.89
Inhibition of human polymorphonuclear leukocyte cell responses by ibuprofen. J Pharm Sci (1984) 0.89
Indomethacin-associated sepsis in very-low-birth-weight infants. Am J Dis Child (1988) 0.87
Protective effects of ibuprofen and methylprednisolone on chemotactic factor-induced transcutaneous hypoxia. J Pharmacol Exp Ther (1986) 0.87
Leukokinesis-enhancing factor in human serum: partial characterization and relationship to disorders of leukocyte migration. Clin Immunol Immunopathol (1979) 0.85
Characteristics of ceftriaxone binding to immunoglobulin G and potential clinical significance. Antimicrob Agents Chemother (1991) 0.82
Cell-directed inhibitor of human leukocyte locomotion. Identification of immunoglobulin G as a cell-directed inhibitor in normal human serum. J Lab Clin Med (1981) 0.82
Inappropriate activation, deactivation, and probable autooxidative damage as a mechanism of neutrophil locomotory defect in trauma. J Infect Dis (1986) 0.81
Treatment of the periodontal component of Papillon-Lefèvre syndrome. J Clin Periodontol (1986) 0.81
Dental treatment of Papillon-Lefèvre syndrome: 15-year follow-up. J Clin Periodontol (1995) 0.80
The role of cellular maturation in neutrophil heterogeneity. Blood (1990) 0.79
Neutrophil heterogeneity in patients with blunt trauma. J Lab Clin Med (1988) 0.78
Quantitating functional capacity of mature and immature (nonsegmented) neutrophils. J Infect Dis (1983) 0.76
Bacteraemia after manipulation of the urinary tract. The importance of pre-existing urinary tract disease and compromised host defences. Postgrad Med J (1978) 0.75
Interference of granulocyte function by the vehicle of miconazole. Antimicrob Agents Chemother (1978) 0.75
Effects of intravenous fat infusion on neonatal neutrophil and platelet function. JPEN J Parenter Enteral Nutr (1990) 0.75
Characterization of a direct effect of phorbol myristate acetate on human neutrophil cell membrane using 31D8 monoclonal antibody. J Leukoc Biol (1992) 0.75
Lomefloxacin concentrations in bone after a single oral dose. Am J Med (1992) 0.75
Institution-specific patterns of infection and Gram's stain as guides for empiric treatment of patients hospitalized with typical community-acquired pneumonia. Pharmacotherapy (1993) 0.75
Simplified micropore filter assay of neutrophil migration using whole blood. J Infect Dis (1983) 0.75
Granulocyte migration abnormality in patients suffering from seasonal allergic rhinitis: failure of treatment with cimetidine. Int Arch Allergy Appl Immunol (1984) 0.75
Reduction in serum concentrations of ciprofloxacin after administration of ursodiol to a patient with hepatobiliary disease. Clin Infect Dis (1994) 0.75
Inhibitors of chemotaxis. Methods Enzymol (1988) 0.75
An audit of chloramphenicol use in a large community hospital. Arch Intern Med (1981) 0.75
IgG inhibitor of polymorphonuclear-leukocyte motility. N Engl J Med (1981) 0.75
Depressed neutrophil chemotaxis in children suffering blunt trauma. Pediatrics (1994) 0.75